| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SOFTOX SOLUTIONS Aktie jetzt für 0€ handeln | |||||
| 08:29 | SoftOx Solutions AS: Third Quarter Report 2025 | - | Oslo Børs | ||
| 14.11. | SoftOx Solutions AS: GMP Drug Substance Successfully Manufactured - Key Milestone for CF and EDF Clinical Programs | - | Oslo Børs | ||
| 16.10. | SoftOx Solutions AS: SoftOx submits Phase 1 Clinical Trial Application under the European Defence Fund Program | - | Oslo Børs | ||
| 13.10. | SoftOx Solutions AS: New Share Capital | 1 | Oslo Børs | ||
| 03.10. | SoftOx Solutions AS: New Share Capital | 8 | Oslo Børs | ||
| 01.10. | SoftOx Solutions AS: Clinical Trial Application for Dose Escalation / Cystic Fibrosis Phase 2a - Important Milestone Achieved | - | Oslo Børs | ||
| 25.09. | SoftOx Solutions AS: Clarification on Placement Commission | - | Oslo Børs | ||
| 25.09. | SoftOx Solutions AS: Private Placements resolved | 1 | Oslo Børs | ||
| 23.09. | SoftOx Solutions AS: SoftOx builds momentum: CF trial strategy reinforced by HOCl stability breakthrough | 4 | Oslo Børs | ||
| 17.09. | SoftOx Solutions AS: Second Quarter/Half-Year Report 2025 | 1 | Oslo Børs | ||
| 11.09. | SoftOx Solutions AS: Softox Solutions AS exercises on the financing facility with Long State Investments Limited | 11 | Oslo Børs | ||
| 08.09. | SoftOx Solutions AS: Presentation Deck and link to today's Investor Update | 1 | Oslo Børs | ||
| 08.09. | SoftOx Solutions AS: Reminder - Investor Update in connection with the Refinement of the Clinical Focus into Chronic Lung Disease Treatment | 1 | Oslo Børs | ||
| 03.09. | SoftOx Solutions AS: Investor Update in connection with the Refinement of the Clinical Focus into Chronic Lung Disease Treatment | - | Oslo Børs | ||
| 02.09. | SoftOx Solutions AS: Refines Clinical Focus and Advances Into Chronic Lung Disease Treatments | 1 | Oslo Børs | ||
| 26.08. | SoftOx Solutions AS: Primary Insider Notification | 1 | Oslo Børs | ||
| 18.08. | SoftOx Solutions AS: New Share Capital | - | Oslo Børs | ||
| 14.08. | SoftOx Solutions AS: Softox Solutions secures committed financing facility | - | Oslo Børs | ||
| 27.06. | SoftOx Solutions AS: SoftOx Solutions AS appoints Dr. Tore Duvold as new board member | 1 | Oslo Børs | ||
| 27.06. | SoftOx Solutions AS: Minutes from the General Meeting | 1 | Oslo Børs |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GENEDX | 167,52 | 0,00 % | GeneDx auf der Jefferies London Konferenz: Strategische Expansion in der Pädiatrie | ||
| PROGYNY | 26,770 | 0,00 % | Progyny, Inc.: New Men's Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action | ||
| ALIGNMENT HEALTHCARE | 19,150 | 0,00 % | Alignment Healthcare stock rating upgraded by JPMorgan to Overweight | ||
| CASTLE BIOSCIENCES | 39,930 | 0,00 % | Castle Biosciences: Starke Wachstumsdynamik und erhöhte Umsatzprognose | ||
| PRIVIA HEALTH GROUP | 24,560 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 32,270 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 36,210 | 0,00 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| ADAPTHEALTH | 9,680 | -1,83 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| SIEMENS HEALTHINEERS | 42,440 | -0,21 % | BARCLAYS stuft Siemens Healthineers auf 'Positiv' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Siemens Healthineers von 61,00 auf 61,50 Euro angehoben und die Einstufung auf "Overweight" belassen. Die Aktienkurse... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,630 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,310 | -0,86 % | FMC, Lanxess, Norma, Redcare Pharmacy, Suss MicroTec, TKMS - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| PACS GROUP | 31,820 | 0,00 % | Morning Market Movers: Mobile-health Network Solutions, PACS Group, Brera Holdings, Cerence See Big Swings | SANTA CLARA (dpa-AFX) - At 7:55 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BILLIONTOONE | 129,90 | 0,00 % | BillionToOne, Inc.: BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares | MENLO PARK, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced... ► Artikel lesen | |
| NUTEX HEALTH | 119,20 | 0,00 % | Nutex Health, Inc.: Nutex Health Reports September 30, 2025 Third Quarter And Year-to-date Financial Results | Total revenue of $723.6 million for the first nine months of 2025 versus $222.3 million for the first nine months of 2024, an increase of 225.5%
Net... ► Artikel lesen | |
| FRESENIUS | 47,330 | -0,69 % | Fresenius SE wackelt - dieser Boden sollte halten | Die Fresenius SE-Aktie steht kurz vor einer wichtigen Unterstützung. Hält der Bereich, oder droht ein Rückfall in tiefere Kursregionen Den vollständigen Artikel lesen ... ► Artikel lesen |